pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·May 8·1 min read
save

Met Gala outfits whimsically matched to biotech logos in annual tradition

May 8, 2026·read at STAT ↗Neutral

The piece highlights an annual tradition of pairing Met Gala attire with the logos of biotech companies, a playful feature in the STAT newsletter The Readout.

For this year’s event, whose theme was "Fashion is Art," the author and colleagues identified several dresses that reminded them of logos from firms such as Gilead and Insilico, though the connections are tongue‑in‑cheek rather than literal.

The article is a light‑hearted cultural commentary and does not report new drug approvals, financial results, or regulatory actions.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “The biotechs wear Prada”

read at STAT ↗
299 words · retrieved May 8
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
GILEAD2Ultragenyx Pharmaceutical Inc.2
topics
Oncology2Rare Disease2ALSDuchenne Muscular DystrophyRecall

related stories

  • Sep 3Capricor, Replimune illustrate why FDA must listen to rare disease specialistsBioSpace
  • Aug 54 potential biotech M&A targets, plus a pretty sure bet from J&JBioSpace
  • Jul 30New funding, new jobs: 4 biotechs hiring after series B raisesBioSpace
  • May 8STAT+: The biotech news you need to read todaySTAT
  • May 7STAT+: FDA revisits a rare cancer treatment it rejected a few months agoSTAT